Contrast-enhanced magnetic resonance imaging of 102 nodules in cirrhosis: correlation with histological findings on explanted livers
暂无分享,去创建一个
Carlo Bartolozzi | Elena Bozzi | Irene Bargellini | Franco Filipponi | C. Bartolozzi | I. Bargellini | V. Battaglia | D. Campani | L. Pollina | Daniela Campani | F. Filipponi | Valentina Battaglia | Luca Emanuele Pollina | E. Bozzi
[1] N. Moriyama,et al. Early hepatocellular carcinoma: appearance at CT during arterial portography and CT arteriography with pathologic correlation. , 1995, Radiology.
[2] A. Demetris. The pathology of liver transplantation. , 1990, Progress in liver diseases.
[3] Myeong-Jin Kim,et al. Gadoxetic acid‐enhanced MRI findings of early hepatocellular carcinoma as defined by new histologic criteria , 2012, Journal of magnetic resonance imaging : JMRI.
[4] C. Park,et al. Dysplastic nodules in liver cirrhosis: evaluation of hemodynamics with CT during arterial portography and CT hepatic arteriography. , 2000, Radiology.
[5] K. Abe,et al. Gd-EOB-DTPA enhanced MRI for hepatocellular carcinoma: quantitative evaluation of tumor enhancement in hepatobiliary phase. , 2005, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.
[6] Carlo Bartolozzi,et al. Biliary and reticuloendothelial impairment in hepatocarcinogenesis: the diagnostic role of tissue-specific MR contrast media , 2007, European Radiology.
[7] P. Robinson,et al. Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings. , 2004, Radiology.
[8] Hwa-Koon Wu,et al. Characterization of cirrhotic nodules with gadoxetic acid‐enhanced magnetic resonance imaging: The efficacy of hepatocyte‐phase imaging , 2010, Journal of magnetic resonance imaging : JMRI.
[9] Rita Golfieri,et al. Contribution of the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI to Dynamic MRI in the detection of hypovascular small (≤2 cm) HCC in cirrhosis , 2011, European Radiology.
[10] J. Bruix,et al. Management of hepatocellular carcinoma: An update , 2011, Hepatology.
[11] E. Hatano,et al. Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma , 2009, Journal of Gastroenterology.
[12] Michiie Sakamoto,et al. Pathologic diagnosis of early hepatocellular carcinoma: A report of the international consensus group for hepatocellular neoplasia , 2009, Hepatology.
[13] Rita Golfieri,et al. Characterization of small nodules in cirrhosis by assessment of vascularity: The problem of hypovascular hepatocellular carcinoma , 2005, Hepatology.
[14] J. Willatt,et al. MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies. , 2008, Radiology.
[15] U. Motosugi,et al. Additional value of gadoxetic acid‐DTPA‐enhanced hepatobiliary phase MR imaging in the diagnosis of early‐stage hepatocellular carcinoma: Comparison with dynamic triple‐phase multidetector CT imaging , 2011, Journal of magnetic resonance imaging : JMRI.
[16] Jae Young Lee,et al. The Value of Gadobenate Dimeglumine-Enhanced Delayed Phase MR Imaging for Characterization of Hepatocellular Nodules in the Cirrhotic Liver , 2008, Investigative radiology.
[17] M. Kudo,et al. Multistep hepatocarcinogenesis from a dysplastic nodule to well-differentiated hepatocellular carcinoma in a patient with alcohol-related liver cirrhosis. , 2007, World journal of gastroenterology.
[18] Y. N. Park,et al. Neoangiogenesis and sinusoidal "capillarization" in dysplastic nodules of the liver. , 1998, The American journal of surgical pathology.
[19] Yong Hwan Jeon,et al. Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. , 2009, AJR. American journal of roentgenology.
[20] H. Edmondson,et al. Primary carcinoma of the liver. A study of 100 cases among 48,900 necropsies , 1954, Cancer.